Category Archive for : ‘Completed Projects’

The integrated anti-HCMV/anti-GBM vaccine

Project title: The integrated anti-HCMV/anti-GBM vaccine

Program – Proof of concept for scientists is intended for financing ideas, concepts, prototypes and intellectual property protection. The emphasis is put on the technological risk, and the main criteria are market orientation and innovativeness.

Grantor: Croatian Agency for SMEs, Innovations and Investments (HAMAG-BICRO)

Grantor’s website: http://www.hamagbicro.hr/

Coordinator: Hrvoje Šimić, MD

Research team:
Suzana Malić, laboratory engineer
Prof. Dr. Stipan Jonjić
Assistant Professor Berislav Lisnić
Lea Hiršl, MA

Total funding (MEDRI): 349.776,99 HRK

Brief description:

Glioblastoma multiforme (GBM) represents the most malignant form of brain tumor. The overall survival prognosis is

GLYCOVAX – A Training Network for the Rational Design of the Next Generation of Well-Defined Glycoconjugate Vaccines

Full title: GLYCOVAX – A Training Network for the Rational Design of the Next Generation of Well-Defined Glycoconjugate Vaccines

Grantor: H2020 Marie Skłodowska- Curie ITN programme

Grant number: 675671

Grantor’s website: http://www.glycovax.eu/

Duration: 01.11.2015-31.10.2019

Coordinator: Novartis Vaccines and diagnostics S.R.L. (NVD), SIENA, Italy

Beneficiary: University of Rijeka Faculty of Medicine (MEDRI)

Total funding: EUR 3.560.797.00

Total funding (MEDRI): EUR 247.761.00

Brief description:

The project aims

Becoming entrepreneurial: Knowledge transfer from the University of Rijeka Faculty of Medicine to the biotechnology business sector

General Info

Full title: Becoming entrepreneurial: Knowledge transfer from the University of Rijeka Faculty of Medicine to the biotechnology business sector

Grantor: Instrument for Pre-Accession Assistance (IPA), component III C, Science and Innovation Investment Fund (SIIF), phase II

Grant number: IPA2007/HR/16IPO/001-040517

Grantor’s website: http://siif2.com/siif/

Additional information about the programme and the Central Financing and Contracting Agency (CFCA – SAFU):  

http://www.safu.hr/hr/o-programima-eu/ipa/ipa-iii/ipa-iiic

Duration: 20 April 2013 – 19 April 2015

Coordinator: Stipan Jonjic, University of Rijeka, Faculty of Medicine

Partner: Martin Messerle, Hannover Medical School

Associates:

–

MCMV Infection of the Developing CNS: Neuroinvasion and Immune Control

Full title: MCMV Infection of the Developing CNS: Neuroinvasion and Immune Control

Grantor: National Institutes of Health

Grant number: 1R01NS065845-01 (Prime Award)

Grantor’s website: http://www.nih.gov/

Duration: 2010-2015

Coordinator: William J Britt, University of Alabama at Birmingham, USA

No. of participants: 2

Partner: Stipan Jonjic, Faculty of Medicine University of Rijeka

Coordinator’s web site: http://www.uab.edu/home/

                                            http://www.microbio.uab.edu/faculty/britt/

Total funding (Sub-award budget): USD 350.000

Brief description:

Congenital human cytomegalovirus (HCMV) infection represents an important cause of neurological damage in children and is the leading cause of non-familial hearing loss in the US. Little is understood

StAdvInn

Full title: Strengthening adaptive immunity via innate immunity: enhancing the CD8 T cell response by using the NKG2D ligand expressed in a herpesvirus vector

Grantor: FP7 – European Research Council (ERC) Advanced Grant

Grant number: 322693

Grantor’s website: http://erc.europa.eu/

Duration: 01 May 2013 – 30 April 2018

Principal investigator: Stipan Jonjic, University of Rijeka Faculty of Medicine

Total funding: EUR 1.754.897

 Brief description:

CD8+ T cells play a key role in the control of infections by intracellular pathogens. Recently, several top-notch studies provided ample evidence that NK cells are important in the regulation of CD8+ T cell response. NKG2D

Congenital CMV and CNS infection mechanisms of protective immunity 

Full title: Congenital CMV and CNS infection mechanisms of protective immunity

Grantor: National Institutes of Health

Grant number:  1R01AI089956-01A1 (Prime Award)

Grantor’s website: http://www.nih.gov/

Duration: 2011-2016

Coordinator: William J Britt, University of Alabama at Birmingham, USA

No. of participants: 4

Partners: – Stipan Jonjic, Faculty of Medicine University of Rijeka

–  Ulrich Koszinowski, Max von Pettenkofer Institute, LMU, Munich, Germany

– Michael Mach, University of Erlangen – Nurnberg, Germany

Coordinator’s web site: http://www.uab.edu/home/ 

http://www.microbio.uab.edu/faculty/britt/

Total funding (Sub-award budget): USD 530.000

Brief description:

Congenital human cytomegalovirus (HCMV) represents the most common viral infection acquired by the developing

VISTRIE

Full title: Viral Strategies of Immune Evasion

Grantor: Helmholtz Association: Helmholtz Virtual Institutes

Grant number: VH-VI-424-4

Grantor’s website: http://www.helmholtz.de/en/research/promoting_research/virtual_institutes/

Project website: http://www.helmholtz-hzi.de/

Duration: 2011-2016

Coordinator: Luka Cicin-Sain, Helmholtz Centre for Infection Research, Germany

No. of participants: 5

Partners: – Martin Messerle, Universität Hannover, Germany

– Ulrich Kalinke, Twincore, Germany

– Hartmut Hengel, Heinrich Heine Universität Düsseldorf, Germany

– Stipan Jonjic, Faculty of Medicine, University of Rijeka

Total funding (Sub-contract): EUR 400.000

  Brief description:

This virtual institute will focus on the interaction of the immune system and the viral infectious agents. The novelty of this concept is to utilize immune evasive genes as tools

Full title: Italo-Croatian Mobility in Europlanning

Grantor: EU Lifelong Learning Programme Leonardo da Vinci – Action Mobility, People in the Labour Market

Grantor’s website: http://ec.europa.eu/education/lifelong-learning-programme/ldv_en.htm 

                             http://www.mobilnost.hr/index.php?id=9                     

Duration: August 2013 – August 2014

Coordinator: Institute for Development and International Relations (IRMO), Zagreb, Croatia

No. of participants: 22 from Croatia, 15 from Italy

Total funding (consortium): EUR 113.655,04

Web page: http://www.irmo.hr/hr/node/1807  

Brief description:

The specific aim of the project is to train 38 newly-graduates, young professionals and unemployed people in the field of EU funded projects in IRMO

Methods for high-throughput glycoproteomic analysis (HTP-GlycoMet)

Full title: Methods for high-throughput glycoproteomic analysis

Grantor: FP7 programme Marie Curie Actions – Industry-Academia Partnerships and Pathways (IAPP)

Grant number: 324400

Grantor’s website:   http://ec.europa.eu/research/mariecurieactions/about-mca/actions/iapp/index_en.htm 

Duration: November 2013 – October 2017

Coordinator: University of Rijeka Department of Biotechnology

Partners: – University of Rijeka Faculty of Medicine (Center for Proteomics)

– Genos d.o.o Zagreb

– Bia Separations, Slovenia

– Max Planck Institutes, Germany

Total funding (consortium): EUR 1.818.077,09 

 Brief description:

The main aim of the HTP-GlycoMet proposal is to develop technologies, which will enable high-throughput analysis of glycosylation of individual proteins from body fluids and cell membranes and apply them to understand some key processes in immunity and infections. Glycan

Platform for trans-Academic Cooperation in Innovation (PACINNO)

Full title: Platform for trans-Academic Cooperation in Innovation 

Grantor: IPA Adriatic Cross Border Cooperation 2007-2013

Grant number: 1°str/0003

Grantor’s website:   http://www.adriaticipacbc.org/     

Project website: http://www.pacinno.eu/ 

Duration: November 2013 – March 2016

Coordinator: University of Trieste, Italy

Partners: – Centre of Excellence for Biosensors, Instrumentation and Process Control (COBIK), Slovenia

– University of Rijeka Faculty of Medicine, Rijeka

– School of Economics and Business in Sarajevo, Bosnia and Herzegovina

– University of Tirana, Albania

– Institute Mihajlo Pupin, Serbia

– Faculty of Economics, Montenegro

– Ionian University, Greece

Total funding (University of Rijeka Faculty of Medicine): EUR 621.427, 22

 Brief description:

The goal of PACINNO is to establish a platform